glp 1 pseudotumor cerebri Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Impact of GLP-1 receptor agonists

Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

They also report that GLP-1 regulates BMSC differentiation fate through AKT signaling

This Phase 1 trial, completed on an accelerated timeline, marks a key milestone in validating both the safety and translational potential of Hanmis next generation triple agonist in humans.Based on these results, Hanmi plans to initiate Phase 2 clinical trials in the second half of 2025, evaluating the long-term effects of HM15275 in reducing body weight and preserving lean mass in patients with severe obesity

To apply, gently remove the patch from the backing and place it on a clean, dry, hair-free area of the skin (such as the upper arm or abdomen)

Discover how to overcome global recruitment and retention challenges in GLP-1 trials for obesity, diabetes, MASH, PCOS, cardiovascular disease, and more.

Simple, easy-to-digest foods for difficult days